Polyethylene Glycol 3350
Product Images NDC 0722-6921

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Polyethylene Glycol 3350 (NDC 0722-6921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nexgen Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

255 G Principal Display Panel (D0d2f068 4453 4ea2 8282 339b6e497a9a 01)

255 G Principal Display Panel (D0d2f068 4453 4ea2 8282 339b6e497a9a 01)
This is a prescription laxative in a powder form for oral solution with the active ingredient of Polyethylene Glycol 3350 NF. The recommended daily dose is 17 grams per day or as directed by a physician, and the dosing cup provided is marked for convenience. The powder should be stirred in 4 to 8 oz. of water, juice, soda, coffee, or tea until completely dissolved before drinking. It may take 2 to 4 days for the product to produce a bowel movement. The medication must be kept out of the reach of children and stored in a controlled room temperature. It is manufactured by Nexgen Pharma, Inc. and distributed by Breckenridge Pharmaceutical, Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.